Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis
Submitted: 7 December 2014
Accepted: 22 January 2015
Published: 5 October 2015
Accepted: 22 January 2015
Abstract Views: 1156
PDF: 787
HTML: 385
HTML: 385
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.